TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

16.00$ -5.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Arcturus Therapeutics Holdings Inc (ARCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 67 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARCT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 6.1 20 13 16 21 9.5 12 206 158 138 67
0.0 0.1 0.3 0.4 17 32 56 174 143 3.0 3.5 3.0
0.0 6.1 20 13 -1.2 21 -46 12 206 158 138 64
25 13 18 16 17 34 58 174 148 192 195 112
5.8 5.0 5.4 7.6 21 13 23 41 46 53 53 46
33 20 25 23 38 46 25 215 194 236 234 139
-33 -20 -25 -10 -22 -26 -72 -203 12 -78 -96 -75
0.0 0.3 0.3 0.2 0.2 0.9 0.8 2.7 3.0 0.8 0.0 0.0
-33 -19 -25 -11 -22 -26 -72 -204 11 -28 -81 -66
0.0 0.1 0.1 0.0 0.2 -0.3 -0.8 3.2 1.3 1.8 0.0 -76
-33 -19 -25 -11 -22 -26 -72 -204 9.3 -30 -81 -66
-33 -1.7 -0.9 -10 -21 -24 -71 -200 15 -24 -77 -63

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?